Evidence map›Paper›PMID 40338415›Full record

ArticleHead and neck pathology2025

New Insights into Ameloblastic Fibromas, Fibrodentinomas, and Fibro-Odontomas: Findings from an International Multicenter Study.

Ana Luiza Oliveira Corrêa Roza, Madhu Shrestha, Hélen Kaline Farias Bezerra, Thamyres Campos Fonsêca, Ciska-Mari Schouwstra, Chané Smit, André Caroli Rocha, Michelle Agostini, Aline Corrêa Abrahão, Letícia Ferreira Cabido and 6 more

Abstract readMulticenter Study
In one paragraph

Article in Head and neck pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ana Luiza Oliveira Corrêa RozaDepartment of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil.ORCID http://orcid.org/0000-0002-4463-9602
Madhu ShresthaDepartment of Diagnostic Sciences, College of Dentistry, Texas A&M University (TAMU), Dallas, USA.ORCID http://orcid.org/0000-0003-1904-3265
Hélen Kaline Farias BezerraDepartment of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil.ORCID http://orcid.org/0000-0002-5236-8988
Thamyres Campos FonsêcaDepartment of Oral Diagnosis and Pathology, School of Dentistry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-4858-3060
Ciska-Mari SchouwstraDepartment of Oral and Maxillofacial Pathology, Faculty of Health Sciences, University of Pretoria (UP), Pretoria, South Africa.ORCID http://orcid.org/0000-0001-5607-8999
Chané SmitDepartment of Oral and Maxillofacial Pathology, Faculty of Health Sciences, University of Pretoria (UP), Pretoria, South Africa.ORCID http://orcid.org/0000-0003-4047-6356
André Caroli RochaMedical School, Clinics Hospital, University of São Paulo (USP), São Paulo, Brazil.ORCID http://orcid.org/0000-0003-0070-0640
Michelle AgostiniDepartment of Oral Diagnosis and Pathology, School of Dentistry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-3648-337X
Aline Corrêa AbrahãoDepartment of Oral Diagnosis and Pathology, School of Dentistry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-3397-3234
Letícia Ferreira CabidoDepartment of Diagnostic Sciences, College of Dentistry, Texas A&M University (TAMU), Dallas, USA.ORCID http://orcid.org/0000-0002-1115-4254
Victoria WooDepartment of Diagnostic Sciences, College of Dentistry, Texas A&M University (TAMU), Dallas, USA.ORCID http://orcid.org/0000-0001-6407-850X
Jacks Jorge JúniorDepartment of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil.ORCID http://orcid.org/0000-0001-8808-8104
Willie F P van HeerdenDepartment of Oral and Maxillofacial Pathology, Faculty of Health Sciences, University of Pretoria (UP), Pretoria, South Africa.ORCID http://orcid.org/0000-0003-2494-667X
John M WrightDepartment of Diagnostic Sciences, College of Dentistry, Texas A&M University (TAMU), Dallas, USA.ORCID http://orcid.org/0000-0003-3924-0602
Mário José RomañachDepartment of Oral Diagnosis and Pathology, School of Dentistry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-7853-5916
Pablo Agustin VargasDepartment of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil. pavargas@unicamp.br.ORCID http://orcid.org/0000-0003-1840-4911

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.722654/2022-00Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/201.340/2022 [272477]Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/201.383/2022 [272817]Texas A and M University 291007-24003
6 · The paper itself

Abstract

introductionAmeloblastic fibroma (AF), ameloblastic fibrodentinoma (AFD), and ameloblastic fibro-odontoma (AFO) are rare mixed odontogenic tumors. While some authors propose that some cases may evolve into odontomas, other tumors with aggressive clinical features suggest a neoplastic origin. A subset of AF and AFD/AFO harbor the pathogenic BRAF p.V600E mutation. SOX9, known for its role in the differentiation of various cell types, particularly in chondrogenesis, has not been previously studied in odontogenic tumors. In this study, we report the clinicopathologic features of a large international cohort of AF and AFD/AFO cases and analyze the immunohistochemical expression of BRAF p.V600E and SOX9. MATERIALS AND

methodsClinical and radiographic data were collected from four Oral and Maxillofacial Pathology service archives spanning from 1991 to 2024. Deidentified slides were reviewed by two independent oral pathologists. Immunohistochemical staining for BRAF p.V600E and SOX9 was performed on non-decalcified tissue samples from cases with available specimens.

resultsA total of 62 tumors were identified, including 30 AF cases and 32 AFD/AFO cases. The cohort consisted of 33 male and 29 female patients, with average ages of 15.3 years for AF and 12.3 years for AFD/AFO. Tumors predominantly affected the posterior mandible and appeared as unilocular or multilocular radiolucent or mixed lesions, often causing tooth impaction and cortical expansion, with an average size of 3.7 cm for AF and 2.5 cm for AFD/AFO. Two cases were classified as peripheral AF/AFD. Microscopically, all cases exhibited cellular mesenchymal components resembling dental papilla, with branching strands and islands of odontogenic epithelium. AFD/AFO cases also displayed dental hard tissue, and occasional chondromyxoid differentiation was observed within the stroma. Rare hybrid tumors were identified, including associations with calcifying odontogenic cysts, cemento-ossifying fibroma and central giant cell granuloma. BRAF p.V600E showed cytoplasmic positivity in the mesenchymal component of AF (81%) and AFD/AFO (54%). SOX9 exhibited diffuse nuclear immunoreactivity in both epithelial and mesenchymal components (92%).

conclusionThis study represents one of the largest well-documented series of AF and AFO/AFD, providing valuable clinicopathologic and immunohistochemical insights. Additionally, the diffuse expression of SOX9 in both epithelial and mesenchymal components suggests a potential role in odontogenic differentiation, a novel finding that may have implications for understanding the histogenesis of these lesions. The aggressive behavior of some AFs and AFD/AFOs in our study supports their classification as odontogenic neoplasms rather than hamartomas.

Indexed as

Jaw NeoplasmsOdontogenic TumorsOdontomaAdolescentAdultBiomarkers, TumorChildFemaleHumansMaleMiddle AgedProto-Oncogene Proteins B-rafSOX9 Transcription FactorYoung AdultBiomarkers, TumorBRAF protein, humanProto-Oncogene Proteins B-rafSOX9 protein, humanSOX9 Transcription FactorAmeloblastic fibromaAmeloblastic fibro-odontomaBRAF p.V600EOdontogenic tumorsSOX9

Identifiers

PMID40338415
PMCPMC12061811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.